Search
Pelthos Therapeutics Ord Shs
PTHSAdd to Watchlist
9.390USD
+0.490+5.51%
Close 11-11 16:00（ET）
36.90MMarket Cap
LossP/E TTM
Today
+5.51%
5 Days
-7.49%
1 Month
-54.20%
6 Months
-65.03%
Year to Date
-69.71%
1 Year
-71.55%
Key Figures
8.720Open
9.610High
1.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
8.900Prev. Close
8.720Low
17.73KTurnover
LossP/E Static
-25.06P/B
0.00%Div Yield TTM
-70.53%ROA
37.40052wk High
0.06Volume Ratio
-7.96MNet Profit
3.93MShares
-22.9164EPS TTM
--Beta
-333.85%ROE
8.72052wk Low
12.13%Amplitude
70.18%Gross Margin
36.90MMarket Cap
0.18Reward/Risk
5.80%Risk Rate
Analyst Rating
Pelthos Therapeutics Ord Shs Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Pelthos Therapeutics Ord Shs Latest Earnings Call Transcripts
Pelthos Therapeutics (PTHS) Q2 2026 Earnings Call: Revenue Rises 45%
Pelthos Therapeutics’ Q2 2026 earnings call covers $15.4 million in net product revenue, 48% prescription growth and planned 2027 product launches.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/-2.16
Revenue / Forecast
--/17.61M
Pelthos Therapeutics Ord Shs Profile
SectorPharmaceuticals
Ticker SymbolPTHS
Number of employees0
Country
Ownership
| Shareholders | Proportion |
|---|---|
| Ligand Pharmaceuticals Inc | 44.70% |
| Murchinson Ltd. | 8.34% |
| Ikarian Capital LLC | 7.62% |
| 3I Management LLC | 6.36% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 48.34% |
| Investment Advisor/Hedge Fund | 17.52% |
| Hedge Fund | 11.77% |
| Individual Investor | 7.78% |
Related Instruments
+0.35%
-0.13%
+0.37%
-0.59%
-1.80%
-0.69%
+0.62%
-0.67%
+0.96%
+0.31%
-0.16%
+0.18%
-0.26%
+0.41%
-1.23%
-0.85%
+4.73%
-0.43%
+0.24%
+0.62%
FAQs
What is the current price of Pelthos Therapeutics Ord Shs (PTHS)?
The current price of Pelthos Therapeutics Ord Shs (PTHS) is 9.39.
What is the symbol of Pelthos Therapeutics Ord Shs?
The ticker symbol of Pelthos Therapeutics Ord Shs is PTHS.
What is the 52-week high of Pelthos Therapeutics Ord Shs?
The 52-week high of Pelthos Therapeutics Ord Shs is 37.40.
What is the 52-week low of Pelthos Therapeutics Ord Shs?
The 52-week low of Pelthos Therapeutics Ord Shs is 8.72.
What is the market capitalization of Pelthos Therapeutics Ord Shs?
The market capitalization of Pelthos Therapeutics Ord Shs is 36.90M.
Is Pelthos Therapeutics Ord Shs (PTHS) currently rated as Buy, Hold, or Sell?
According to analysts, Pelthos Therapeutics Ord Shs (PTHS) has an overall rating of Buy, with a price target of 49.57.
What is the Earnings Per Share (EPS TTM) of Pelthos Therapeutics Ord Shs (PTHS)?
The Earnings Per Share (EPS TTM) of Pelthos Therapeutics Ord Shs (PTHS) is -22.92.